image imagewidth (px) 210 935 | latex stringlengths 165 6.04k | filename stringlengths 17 19 |
|---|---|---|
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Scale} & \multicolumn{4}{|l|}{\textbf{Self-report}} & \multicolumn{4}{|l|}{\textbf{Proxy-report}} \\
\hline
& \textbf{N} & \textbf{Mean (sd)} & \textbf{df} & \textbf{F} & \textbf{N} & \textbf{Mean (sd)} & \textbf{df} & \textbf{F} \\
\hl... | PMC1079918_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\multicolumn{2}{|l|}{\textbf{Rate of PTSD symptoms on the K-SADS}} & \multicolumn{2}{|l|}{\textbf{Rate of PTSD symptoms on the CATS}} \\
\hline
\textbf{symptom} & \textbf{\%} & \textbf{symptom} & \textbf{\%} \\
\hline
\multicolumn{4}{|l|}{Comparable Sympt... | PMC1088008_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{A.} & \multicolumn{12}{|l|}{\textbf{HPV cLIA time (weeks)}} \\
\hline
\textbf{HPV type} & \textbf{0} & \textbf{2} & \textbf{4} & \textbf{8} & \textbf{10} & \textbf{12} & \textbf{16} & \textbf{20} & \textbf{24} & \textbf{26} & \te... | PMC1097753_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Index} & \textbf{N} & \multicolumn{2}{|l|}{\textbf{Groups}} & \textbf{P $<$ :} \\
\hline
& & \textbf{Control (+/+)} & \textbf{Diabetes (db/db)} \\
\hline
Body Weight (g) & 5 & 21 $\pm$ 3 & 47 $\pm$ 5 & 0.001 \\
\hline
Blood Glucose (mg/dl) & 5... | PMC1097758_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Functional type} & \textbf{Fluffy tails (F$>$2)} & \textbf{No fluffy tails (F$<$2)} & \textbf{Positive rate} & \textbf{Negative rate} \\
\hline
Regulatory regions & 51 & 9 & 85 \% & 15 \% \\
\hline
Exons & 1 & 59 & 1.6 \% & 98.4 \% \\
\hline
Non... | PMC1127108_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Protein family} & \textbf{PDB ID} & \textbf{Correct} & \textbf{Useful info} & \textbf{Wrong} \\
\hline
\multicolumn{5}{|l|}{A. Proteins from Table 1} \\
\hline
Acetyglucosamine-6-phoshate deacyetylaseb & 1O12 & 6 & 1 & 0 \\
\hline
Alcohol dehydr... | PMC1142304_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Characteristic} & \multicolumn{6}{|l|}{\textbf{Genotype [n (\%)]}} \\
\hline
& \textbf{CYP2D6*1/*1} & \textbf{CYP2D6*1/*4} & \textbf{CYP2D6*4/*4} & \textbf{SULT1A1*1/*1} & \textbf{SULT1A1*1/*2} & \textbf{SULT1A1*2/*2} \\
\hline
\multicolumn... | PMC1143572_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Env – gp41} & \textbf{573} & \textbf{631} & \textbf{676} & \textbf{713} & \textbf{734} & \textbf{737} & \textbf{741} & \textbf{751} & \textbf{752} & \textbf{760} & \textbf{764} & \textbf{767} & \textbf{785} & \textbf{80... | PMC1145188_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Finding} & \textbf{BASDAI} & \textbf{BASMI} & \textbf{BASFI} & \textbf{PatGA} & \textbf{PhysGA} & \textbf{NRS-P} & \textbf{ESR (mm/h)} & \textbf{CRP (mg/l)} \\
\hline
\multicolumn{9}{|l|}{At time point 1a} \\
\hline
Mean $\pm$ SD & 2.5 $... | PMC1174938_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Proliferation marker} & \textbf{rs} & \textbf{P} \\
\hline
Thymidylate synthase & 0.38 & $<$0.001 \\
\hline
Thymidine kinase 1 & 0.23 & $<$0.01 \\
\hline
Survivin & 0.22 & $<$0.01 \\
\hline
E2F & 0.22 & $<$0.01 \\
\hline
II$\alpha$ Topoisomerase & 0... | PMC1175052_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Patient characteristics} & \multicolumn{6}{|l|}{\textbf{CYP17 genotype}} \\
\hline
& \multicolumn{2}{|l|}{\textbf{A1/A1 (n = 503)}} & \multicolumn{2}{|l|}{\textbf{A1/A2 (n = 668)}} & \multicolumn{2}{|l|}{\textbf{A2/A2 (n = 260)}} \\
\hline
... | PMC1175058_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{EM operation} & \textbf{Definition} \\
\hline
Overlap (x y) ❍ & x and y overlap if they have a part in common. \\
\hline
ι Disjoint (x y) & x and y are disjoint if they share no parts in common. \\
\hline
Binary product (x . y) & The parts that x and ... | PMC1175956_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Parameter} & \textbf{Group 1 n = 19} & \textbf{Group 2 n = 19} & \textbf{Group 3 n = 18} & \textbf{One-way ANOVA, F-Value} & \textbf{P value} \\
\hline
Age & 69.6 $\pm$ 9.2 & 65.8 $\pm$ 7.8 & 70.8 $\pm$ 9.9 & 1.58 & NS \\
\hline
ACD & 2.6 $\pm... | PMC1180454_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
& \textbf{Type II cells + C. pneumoniae} & \textbf{Macrophages + C. pneumoniae} & \textbf{Type II cells – 10\% macrophages} \\
\hline
0 min & 160 $\pm$ 21 & 231 $\pm$ 22 & 137 \\
\hline
30 min & 210 $\pm$ 93 & 439 $\pm$ 49 & 166 \\
\hline
1 hour & 509 $\... | PMC1180473_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
& \multicolumn{3}{|l|}{\textbf{Low A}} & \multicolumn{3}{|l|}{\textbf{Low B}} \\
\hline
& \textbf{Observed} & \textbf{RR} & \textbf{p-value} & \textbf{Observed} & \textbf{RR} & \textbf{p-value} \\
\hline
Not Adjusted & 440 & 0.81 & 0.004 & * & * &... | PMC1180846_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Group} & \textbf{Patient Number} & \textbf{Refracted Va two months post surgery} & \textbf{Last Va} & \textbf{Macula clinically dry at two weeks} & \textbf{Macula clinically dry at last FU} \\
\hline
A & 1 & 6/9 & 6/18 & Yes & Yes \\
\hline
&... | PMC1183218_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Group} & \textbf{Patient Number} & \textbf{Follow up (months)} & \textbf{Raised IOP} & \textbf{Stepwise deterioration in retinopathy grade at last FU (ETDRS)} \\
\hline
A & 1 & 15 & & 3 \\
\hline
& & 14 & & 1 \\
\hline
A & 2 & 6 & & 0 \\
\h... | PMC1183218_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Study} & \textbf{Year} & \textbf{Country} & \textbf{Type of cardiac surgery} & \textbf{Interventions} \\
\hline
Isetta et al. [25] & 1993 & France & NR & HD APR (n = 70) vs. LD APR (n = 70) vs. TXA (n = 70) vs. Control (n = 70) \\
\hline
Blauhut... | PMC1185524_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \multicolumn{4}{|l|}{\textbf{Developmental outcome (Odds ratio and 95\% confidence interval) PARENT COMPLETED}} \\
\hline
\\
\hline
& \textbf{Motor} & \textbf{Speech \& language} & \textbf{Behaviour} & \textbf{Cognition} \\
\hline
All centres (N = ... | PMC1199601_table_4 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Variable} & \textbf{Definition} \\
\hline
\multicolumn{2}{|l|}{Dependent Variable} \\
\hline
Expenditures & Continuous variable: total household annual out-of-pocket medical expenditures \\
\hline
\multicolumn{2}{|l|}{Independent Variable} \\
\hline
D... | PMC1208885_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
& \textbf{SF-12 Mental Health Component} & \textbf{SF-12 Physical Health Component} & \textbf{SF-12 General Health Perception} \\
\hline
Age & NS & NS & NS \\
\hline
Body Mass Index & r = -0.213 p = 0.021* & r = -0.262 p = 0.004* & r = -0.272 p = 0.003* ... | PMC1208910_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Age} & \textbf{Sample Size} & \textbf{Mean} & \textbf{S.E.} & \textbf{Ratio Index} \\
\hline
19–30 years & 5 & 78980 & 15580 & 5.1 \\
\hline
31–35 years & 13 & 25300 & 4860 & 2.1 \\
\hline
36–40 years & 14 & 21450 & 2650 & 4.7 \\
\hline
41–45 ye... | PMC1215522_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Source} & \multicolumn{2}{|l|}{\textbf{dChip}} & \multicolumn{2}{|l|}{\textbf{MAS 5.0}} & \multicolumn{2}{|l|}{\textbf{RMA}} & \multicolumn{2}{|l|}{\textbf{GCRMA-EB}} \\
\hline
& \textbf{Mean} & \textbf{SD} & \textbf{Mean} & \textbf{SD}... | PMC1232851_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{SAMPLES} & \textbf{RT-PCR} & \textbf{P503S} & \textbf{P504S} & \textbf{P510S} \\
\hline
PB & & No (\%) & No (\%) & No (\%) \\
\hline
\multicolumn{5}{|l|}{group 1} \\
\hline
AA and RP (n = 11) & positive & 7 (63.63) & 7 (63.63) & 11 (100) \\
\hl... | PMC1236915_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Group} & \textbf{Animals (n)} & \textbf{Total Cells ($\times$ 104/total BAL)} & \textbf{Macrophages ($\times$ 104/ total BAL)} & \textbf{Eosinophils ($\times$ 104/ total BAL)} & \textbf{Neutrophils ($\times$ 104/ total BAL)} & \textbf{Mononu... | PMC1242256_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Parameter} & \textbf{Description} & \textbf{Value} \\
\hline
C\% & Pattern conservation & 95\% (dog) 90\% (rat) \\
\hline
L & Maximum pattern length & 25 amino acids \\
\hline
S & Research complexity & High (E = 0; dog) Medium (E = 1; rat) \\
\hline... | PMC1257466_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Gene} & \textbf{$\rightarrow$ Forward \& reverse primers 5' 3'} & \textbf{[C] a} & \textbf{Amplicon size (bp)} & \textbf{Tm b (°C)} & \textbf{Slope} & \textbf{R2c} & \textbf{E d} \\
\hline
ACTB & ATGCCTCCTGCACCACCA GCATTTGCGGTGGACGAT & 300... | PMC1262732_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{MR diagnosis} & \textbf{No. of cases} \\
\hline
White-matter signal abnormalities & 113 \\
\hline
Lacunar infarction & 31 \\
\hline
Old lobar or cerebellar infarction & 13 \\
\hline
Venous malformation & 6 \\
\hline
Arachinoid cyst in the middle crani... | PMC1266373_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Variable} & \textbf{Coefficient} & \textbf{Standard error} & \textbf{OR} & \textbf{95\% CI of OR} & \textbf{p-value} \\
\hline
cTnI & 1.04 & 0.6 & 2.82 & 0.87–9.2 & 0.085 \\
\hline
APACHE II & 0.09 & 0.03 & 1.094 & 1.02–1.17 & 0.009 \\
\hline
... | PMC1269455_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
& \textbf{Cont 3 M} & \textbf{Cont 6 M} & \textbf{Cont 11 M} & \textbf{Cont 21 M} & \textbf{Inulin 3 M} & \textbf{Inulin 6 M} & \textbf{Inulin 11 M} & \textbf{Inulin 21 M} & \textbf{inulin} & \textbf{age} & \textbf{interaction} \\
\hline
... | PMC1283151_table_4 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
& & \multicolumn{2}{|l|}{\textbf{Multiple regrafts}} \\
\hline
\textbf{No of eyes (n = 53)} & \textbf{1 regraft (n = 37)} & \textbf{2 regraft (n = 14)} & \textbf{3 regraft (n = 2)} \\
\hline
Clear regrafts (n = 28) & 25 & 3 & 0 \\
\hline
Failed regrafts... | PMC1291374_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\multicolumn{3}{|l|}{\textbf{Have you ever been treated for thyroid disease in the past?}} \\
\hline
\textbf{Yes} & \multicolumn{2}{|l|}{\textbf{No}} \\
\hline
\textbf{If yes (multiple yes answers are possible)} \\
\hline
Was this called Graves' disease? & ... | PMC1308850_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{European haplotypes} \\
\hline
Method & MAF & Number of Blocks & Mean bp/block & Mean SNPs/block & \% coverage \\
\hline
HapBlock & 0.1\% & 180 & 951.63 & 7.49 & 85.6\% \\
\hline
HapBlock & 10\% & 48 & 3363.60 & 7.64 & 80.7\% \\
\hline
Gabriel... | PMC1343594_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Type of post consultation letter} & \textbf{Letter to General Practitioner} & \textbf{Letter to patient} & \textbf{Significance (Wilcoxin Signed Ranks test)} \\
\hline
Length of time to dictate letter (minutes $\pm$ SD, n) & 3.28 $\pm$ 2.2, 81 & 2... | PMC1360088_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Infection} & \textbf{Number of infections among Saudi patients (\%)} & \textbf{Average annual incidence of infections per 100,000 Saudi population} & \textbf{Number of infections among non-Saudi patients (\%)} & \textbf{Average annual incide... | PMC1368987_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Treatment} & \textbf{Fractional turnover rate r day-1} & \textbf{Modeled versus observed value r2} \\
\hline
1 & 0.34 & 0.6563 \\
\hline
2 & 0.15 & 0.6984 \\
\hline
3 & 0.16 & 0.8011 \\
\hline
5 & 0.40 & 0.6411 \\
\hline
6 & 0.57 & 0.9498 \\
\hline
... | PMC1373641_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \textbf{1-1 orth} & \textbf{most cons X-X} & \textbf{less cons X-X} & \textbf{random non-orth} \\
\hline
all X-X orth & 6.31·10-233 & 0 & 1.78·10-70 & 3.55·10-21 \\
\hline
random non-orth & 9.66·10-173 & 0 & 0.172 & . \\
\hline
less cons X-X & 0 & 0 ... | PMC1382217_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
& \multicolumn{2}{|l|}{\textbf{dvSalt30}} & \multicolumn{2}{|l|}{\textbf{ecox}} & \multicolumn{2}{|l|}{\textbf{shHeat5}} & \multicolumn{2}{|l|}{\textbf{shCold5}} \\
\hline
\textbf{Method} & \textbf{\#Genes} & \textbf{\%Agree} & \textbf{\#Genes}... | PMC1397872_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Characteristics} & & \multicolumn{3}{|l|}{\textbf{Women}} & \multicolumn{3}{|l|}{\textbf{Men}} \\
\hline
& & \textbf{Total} & \multicolumn{2}{|l|}{\textbf{Current smoker}} & \textbf{Total} & \multicolumn{2}{|l|}{\textbf{Current smoker}}... | PMC1403766_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \textbf{Total (n = 115)} & \textbf{MI (n = 24)} & \textbf{No MI (n = 91)} & \textbf{P value} \\
\hline
Age (years; mean $\pm$ SD) & 64.1 $\pm$ 17.2 & 62.8 $\pm$ 18.3 & 64.4 $\pm$ 17.0 & 0.69 \\
\hline
Sex (n; \% female) & 61 (53.0) & 13 (54.2) & 48 (... | PMC1414005_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{AAA model} & \textbf{P (mmHg)} & \textbf{dAAA,max (cm)} & \textbf{Thickness t (cm)} & \textbf{$\alpha$} & \textbf{$\beta$} & \textbf{Stress (Authors' results) (MPa)} & \multicolumn{2}{|l|}{\textbf{Modified Laplace Equation}} & \multi... | PMC1421417_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Dataset} & \textbf{INTACT_HO} & \textbf{INTACT_GAVIN} & \textbf{INTACT_ITO} & \textbf{INTACT_UETZ} & \textbf{INTACT_SMALL} \\
\hline
DIP_CORE & 28.90 & 48.60 & 13.60 & 31.60 & 29.60 \\
\hline
DIP_FULL & 85.10 & 75.20 & 91.80 & 87.70 & 29.60 \\... | PMC1431566_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Patient} & \textbf{Age} & \textbf{APACHE} & \textbf{MBP} & \textbf{HR} & \textbf{CREAT} & \textbf{TROP T} & \textbf{Infection} & \textbf{Germ} & \textbf{AB} \\
\hline
MAPRR & 20 & 6 & 145 & 129 & 0.8 & $<$0.01 & Blood & S. aureus & van... | PMC1434771_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Survey sample} & \textbf{Total respondents} & \textbf{Mean score of all respondents (SD)} & \textbf{Range of scores of all respondents (SD)} & \textbf{Total SDOLs} & \textbf{Mean score of self- designating opinion leaders (SD)} & \textbf{Ran... | PMC1436013_table_6 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Window size} & \multicolumn{4}{|l|}{\textbf{Prediction accuracy (\%)}} \\
\hline
& \textbf{Q2} & \textbf{MCC} & \textbf{Sensitivity} & \textbf{Specificity} \\
\hline
3 & 61.2 & 0.22 & 64.4 & 57.9 \\
\hline
5 & 62.5 & 0.25 & 63.3 & 61.6 \\
\hlin... | PMC1450308_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Effect Size} & \textbf{Failure Rate 95\%} & \textbf{Failure Rate 98\%} \\
\hline
30\% & 235 & 195 \\
\hline
33.3\% & 185 & 160 \\
\hline
35\% & 160 & 140 \\
\hline
40\% & 120 & 95 \\
\hline
\end{tabular}}
\end{table} | PMC1459124_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\multicolumn{7}{|l|}{\textbf{All}} \\
\hline
\textbf{Crops} & \textbf{AECD-Blocks} & \textbf{General feeder (Polyphagous)} & \textbf{Oligophagous} & \textbf{Monophagous} & \textbf{No crop attacked} & \textbf{Absent in the village} \\
\hline
Annual c... | PMC1464119_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{year in} & \textbf{Incidence (1/100,000)} & \textbf{Moran 's I} & \textbf{E [I]} & \textbf{p} \\
\hline
1994 & 5.16 & 0.2672 & 0.0005 & 0.001 \\
\hline
1995 & 4.94 & 0.4374 & 0.0005 & 0.001 \\
\hline
1996 the & 3.65 & 0.5153 & 0.0005 & 0.001 \\
... | PMC1471792_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Gene product} & \textbf{Forward primer} & \textbf{Reverse primer} \\
\hline
SP-B & 5'-GCCATGGCCAAGTTACATCT-3' & 5'-TGCTCACACTTTTGCCTGTC-3' \\
\hline
SP-C & 5'-TACTCGACAGGTCCCAGGAG-3' & 5'-AGCTCTCCACACAAGGTGCT-3' \\
\hline
CC10 & 5'-CAACATCAGCCCACATC... | PMC1475638_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Source} & \textbf{DF} & \multicolumn{5}{|l|}{\textbf{F value}} \\
\hline
& & \textbf{Critical} & \textbf{Dorsal vein} & \textbf{Caudal vein} & \textbf{Dorsal artery} & \textbf{Caudal artery} \\
\hline
Family & 3 & 2.91 & 11.35* & 1.35 & 8.... | PMC1479343_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Influencing factor} & \textbf{Examples} \\
\hline
\multicolumn{2}{|l|}{Epidemiological environment} \\
\hline
Prevalence of condition & Screening and referral programs for breast cancer \\
\hline
Incidence of condition & Preventive measures for many i... | PMC1479369_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Item} & \textbf{Spearman Correl. (rho)} & \textbf{N} \\
\hline
Tangibles 1 & 0.910 & 27 \\
\hline
Tangibles 2 & 0.914 & 27 \\
\hline
Tangibles 3 & 0.931 & 27 \\
\hline
Tangibles 4 & 0.932 & 26 \\
\hline
Responsiveness 5 & 0.952 & 27 \\
\hline
Respon... | PMC1482701_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Primer} & & \textbf{Sequence} & \textbf{Size of product (bp)} \\
\hline
PAR-1 & sense & 5'-CAGCTCCTGGCTGACACTCTTTGTC-3' & 500 \\
\hline
& antisense & 5'-CGAGCAGGGTTTCATTGAGCACAT-3' \\
\hline
PAR-2 & sense & 5'-GCAGCCTCTCTCTCCTGCAGTGG-3' & 461 \\... | PMC1489934_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{(µg/ml) Compound} & \textbf{IL-8 released (pg/ml)} \\
\hline
Medium alone & 24.6 $\pm$ 1.5 \\
\hline
Tryptase 2.0 & 105.2 $\pm$ 5.3* \\
\hline
Elastase 0.3 & 108.4 $\pm$ 13.2* \\
\hline
Benzamidine 30 & 37.6 $\pm$ 4.4 \\
\hline
Leupeptine 30 & 27.4 $\... | PMC1489934_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
& \textbf{Disease} & \textbf{Polymorphism} & \textbf{Total} \\
\hline
Number of nsSNPS & 10,419 & 4217 & 14,636 \\
\hline
Number of nsSNPS within proteins with structural homologs & 3212 & 609 & 3821 \\
\hline
Number of Proteins with nsSNPs & 893 & 1256 ... | PMC1489951_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Site} & \textbf{Disease} & \textbf{Polymorphisms} & \textbf{Percentage (odds ratio) of nsSNPs within these sites that are disease} \\
\hline
ACT_SITE & 25 & 1 & 96.15 (10.12) \\
\hline
BINDING & 13 & 0 & 100 (-) \\
\hline
DNA_BIND & 352 & 20 & 94.... | PMC1489951_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
& \textbf{n (\%)} \\
\hline
Respondent shopping for self and child(ren) & 44 (91.7) \\
\hline
Respondent shopping for self and spouse & 25 (52.1) \\
\hline
\multicolumn{2}{|l|}{Self-report of diagnosis by a physician for any household member:} \\
\hline
High... | PMC1508155_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Population health indicator} & \textbf{Australia (Rank)} & \textbf{Country with best outcome (outcome)} \\
\hline
Life expectancy at birth (years) & 79 (3rd) & Japan (82) \\
\hline
Infant mortality rate per 1000 & 6 (4th) & Japan, Singapore, Sweden ... | PMC1513585_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \textbf{Unadjusted} & \textbf{Adjusted for age} & \textbf{Adjusted for age and SBP†} & \textbf{Adjusted for age, SBP† and pack-years} \\
\hline
CPITN† score & 1.41* [1.16–1.73] & 0.98 [0.77–1.25] & 0.86 [0.65–1.13] & 0.91 [0.68–1.20] \\
\hline
Averag... | PMC1524747_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
& \textbf{Wave 1} & \textbf{Wave 2} & \textbf{Wave 3} & \textbf{Wave 4} & \textbf{Wave 5} & \textbf{Unique Individuals} \\
\hline
& (n = 124) & (n = 106) & (n = 115) & (n = 113) & (n = 115) & n = 251 \\
\hline
Age (mean; [sd]) & 41.6 [10.7] & 40.9... | PMC1524956_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \multicolumn{2}{|l|}{\textbf{Depressed vs. non-depressed}} & \multicolumn{2}{|l|}{\textbf{Responders vs. non-responders}} \\
\hline
\textbf{Polymorphism} & \textbf{p-value} & \textbf{q-value} & \textbf{p-value} & \textbf{q-value} \\
\hline
rs6280 DRD... | PMC1526442_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Physiological functions} & \textbf{A} & \textbf{B} & \textbf{C} \\
\hline
Replenishment of water & Isotonic drinks & Hypotonic drinks Glycerol \\
\hline
Improvement of endurance & High-carbohydrate Citric acid & Arginine Caffeine Carnitine & Capsa... | PMC1526446_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
& \multicolumn{4}{|l|}{\textbf{PADI4 haplotype (frequencies)}} & \multicolumn{4}{|l|}{\textbf{PADI4 haplotype (carriers)}} \\
\hline
& \textbf{Haplotype 1} & \textbf{Haplotype 1B} & \textbf{Haplotype 2/3} & \textbf{Haplotype 4} & \textbf{Haplo... | PMC1526594_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
Female (\%) & 72 \\
\hline
Mean age (years) & 50.7 \\
\hline
Mean disease duration (months) & 4.3 \\
\hline
Pain (100 mm VAS) & 54.4 \\
\hline
Morning stiffness (minutes) & 84 \\
\hline
Ritchie index & 17.8 \\
\hline
Tendon joint count & 21.8 \\
\hline
Swolle... | PMC1526612_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Variable} & \multicolumn{2}{|l|}{\textbf{Unemployment Duration (\%/n)}} & \textbf{t (p)} \\
\hline
& \textbf{Short-term N = 234} & \textbf{Long-term N = 195} \\
\hline
\multicolumn{4}{|l|}{Depression (in past 12 months)} \\
\hline
Never & 15.8/37... | PMC1526724_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Haplogroups} & \textbf{Diagnostic coding region substitutions} \\
\hline
M2 & 447G-1780-8502-11083-15670 \\
\hline
M2a & 5252-7961-8396-9758-12810 \\
\hline
M3 & 482 \\
\hline
M3a & 4580 \\
\hline
M4a & 6620-7859 \\
\hline
M4b & 511 \\
\hline
M5 & 188... | PMC1534032_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{OBS} & \textbf{SNP} & \textbf{N_h} & \textbf{CPA_H} & \textbf{s.e.} & \textbf{CPA_U} & \textbf{s.e.} & \textbf{CPA_G} & \textbf{s.e.} \\
\hline
1 & 680 & 13 & 1.259 & 0.032 & 1.221 & 0.014 & 1.252 & 0.022 \\
\hline
2 & 659 & 40 & 0.765 &... | PMC1539032_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Authors} & \textbf{Year} & \textbf{Main findings} \\
\hline
Johnson et al. & 2004 & Germline stem cells are located within the ovarian epithelium and supply the adult mouse ovary with new oocytes. \\
\hline
Johnson et al. & 2005 & Germline stem cell... | PMC1553467_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Proteins} & \textbf{Value} & \textbf{Number of connections} & \textbf{GO Molecular Function annotation} \\
\hline
CLA4 (YNL298W) & -0.41 & 91 & protein serine/threonine kinase activity \\
\hline
FKS1 (YLR342W) & -0.34 & 90 & 1,3-beta-glucan syntha... | PMC1557866_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Variable (unit)} & \textbf{Odds ratio (CI)*} \\
\hline
\multicolumn{2}{|l|}{Abnormally low semen count ($<$ 20 $\times$ 106)} \\
\hline
Abnormally low basal inhibin ($<$ 100 pg/ml) & 8.2 (1.4–49.2) \\
\hline
Age (years) & 1.0 (0.92–1.1) \\
\hline
Abst... | PMC1560382_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Plasma (acyl)carnitine} & \textbf{Non Responders} & \textbf{Responders} & \textbf{P} \\
\hline
($\mu$mol/L) & Mean (SD) & Mean (SD) \\
\hline
Free carnitine & 36.6 (9.3) & 34.7 (8.3) & 0.374 \\
\hline
C2-carnitine & 5.9 (2.6) & 4.8 (1.7) & 0.023 \... | PMC1562448_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{District (DHA only)} & \textbf{Service Expenditure (Cedis)} & \textbf{Service Expenditure (US\$)*} & \textbf{Service Expenditure per 100 people (US\$)} \\
\hline
\multicolumn{4}{|l|}{Northern} \\
\hline
Tamale municipal & 39,019, 000 & 4,758.41 & ... | PMC1563463_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Childhood workforce participation age 10–15†} & \textbf{Adult workforce participation age 30–35} & \textbf{Adult workforce participation age 40–45} & \textbf{Social mobility category*} & \textbf{Men n (\%)} & \textbf{Women n (\%)} \\
\hline
In... | PMC1569840_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \textbf{Frequency (n = 46)} & \textbf{SRO1} & \textbf{Size (Mb)} & \textbf{Genomic position (Mb)} \\
\hline
\multicolumn{5}{|l|}{Losses} \\
\hline
8p & 67.4\% & 8p21.2-8p22 & 12.0 & 15.36–27.36 \\
\hline
5q & 39.1\% & 5q13.1 5q13.2-5q13.3 5q21.1 5q22... | PMC1570364_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \multicolumn{2}{|l|}{\textbf{Patients with schizophrenia}} & \multicolumn{2}{|l|}{\textbf{Non-psychiatric subjects}} \\
\hline
& \textbf{BMI $<$ 28} & \textbf{$\geq$ BMI 28} & \textbf{BMI $<$ 28} & \textbf{$\geq$ BMI 28} \\
\hline
& N = 20 & N = 20... | PMC1570457_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \multicolumn{2}{|l|}{\textbf{Breast cancer N = 3593}} & \multicolumn{2}{|l|}{\textbf{BC controls N = 9098}} \\
\hline
\textbf{Age at diagnosis (mean, SD)} & \textbf{54.6} & \textbf{9.3} & \textbf{50.6} & \textbf{10.1} \\
\hline
& N & \% & N & \% \\
... | PMC1574290_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Study, location and reference} & \textbf{Number of Patients} & \textbf{Study Design} & \textbf{Age * (years)} & \textbf{CD4 Cell Count**} & \textbf{Vaccine strains} & & \textbf{Comparator} \\
\hline
Tasker 1999, USA, [26] & 102 & Randomiz... | PMC1574329_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Patient ID} & \textbf{Age (years)} & \textbf{Sex} & \textbf{Status} & \textbf{Atopy} & \textbf{FEV1 (L)} & \textbf{FEV1 \% pred} & \textbf{FVC (L)} \\
\hline
1 & 34 & M & Normal & NA & 4.5 & 110 & 6.2 \\
\hline
3 & 25 & M & Normal & A & 4.... | PMC1579218_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Year} & \textbf{Estimated population\#} & \textbf{Birth cohort} & \textbf{Vaccination coverage*} & \textbf{Vaccine efficacy**} & \textbf{Children susceptible} & \textbf{Cumulated susceptible population} \\
\hline
1988 & 2,076,264 & 44,432 & ... | PMC1586205_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{n} & \textbf{\# code words – 4n/2} & \textbf{Coloring bound} & \textbf{Sphere packing bound} \\
\hline
3 & 32 & 18 & 3 \\
\hline
4 & 128 & 42 & 9 \\
\hline
5 & 512 & 95 & 32 \\
\hline
6 & 2,048 & 210 & 107 \\
\hline
7 & 8,192 & 460 & 372 \\
\hline... | PMC1590034_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
& \textbf{Fruit intake} & \textbf{N} & \textbf{$\beta$a} & \textbf{95\% CI} & \textbf{Vegetable intake N} & \textbf{$\beta$b} & \textbf{95\% CI} \\
\hline
\\
\hline
Model 1 & boys & 249 & 0.02 & -0.21; 0.25 \\
\hline
& girls & 280 & 0.37 & 0.15... | PMC1599740_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
Class & \multicolumn{14}{|l|}{3 1065 [336]} \\
\hline
Subclass & 3.1 267 [113] & \multicolumn{2}{|l|}{3.2 163 [56]} & 3.3 10 [4] & 3.4 317 [49] & 3.5 171 [70] & 3.6 109 [36] & 3.7 10 [4] & 3.8 10 [1] & 3.9 1 [1] & 3.10 2 [1] & 3.11 2... | PMC1609188_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\multicolumn{2}{|l|}{\textbf{No. of patients (n = 34)}} \\
\hline
\textbf{Sex} \\
\hline
Male/Female & 23/11 \\
\hline
\multicolumn{2}{|l|}{Age (years)} \\
\hline
Median/Range & 57/15–90 \\
\hline
\multicolumn{2}{|l|}{Site of involvement and} \\
\hline
Conjun... | PMC1630703_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Sample} & \textbf{M} & \textbf{N} & \textbf{H} & \textbf{AA \%} & \textbf{DNA \%} & \textbf{dN/dS} & \textbf{PNGS} & \textbf{V1V5 length} & \textbf{Co-receptor usage} & \textbf{Cause of death} \\
\hline
1449 i02m & 2 & 26 & 21 & 0.6 ... | PMC1635063_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Author} & \textbf{Condition} & \textbf{QUADAS Score} \\
\hline
Laslett et al [8] & Sacroiliac Joint Pain/Dysfunction & 12 \\
\hline
Laslett et al [9] & Sacroiliac Joint Pain/Dysfunction & 11 \\
\hline
Shah \& Rajshekhar [10] & Soft Cervical Disc Pro... | PMC1635718_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Authors} & \textbf{No. of Subjects} & \textbf{Test} & \textbf{Sensitivity (\%)} & \textbf{Specificity (\%)} & \textbf{QUADAS Score} \\
\hline
Thomas et al [24] & 297 & Kernig & 5* & 95* \\
\hline
& & & 9** & 96** & 7 \\
\hline
& & & 0***... | PMC1635718_table_7 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Village} & \textbf{Paddy category} & \textbf{No. of Habitats} & \textbf{1stinstars} & \textbf{2nd instars} & \textbf{3rd instars} & \textbf{4th instars} & \textbf{Pupae} \\
\hline
Kangichiri & Ploughed & 25 & 1.41 & 0.95 & 0.09 & 0.00 & 0.... | PMC1636646_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Characteristic} & & & & \multicolumn{3}{|l|}{\textbf{No NASH vs Borderline or NASH}} & \multicolumn{3}{|l|}{\textbf{NASH vs Borderline or No NASH}} \\
\hline
& \textbf{No NASH n = 98} & \textbf{Borderline NASH n = 96} & \textbf{NAS... | PMC1657015_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Citation} & \textbf{Intervention} & \textbf{Study Population Total (Control/Intervention)} & \textbf{Follow-up \& Assessment method} & \textbf{Outcomes} \\
\hline
Cline et al. (Sweden) & Education on heart failure for patients and their families... | PMC1660572_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \multicolumn{2}{|l|}{\textbf{Heifers}} & \multicolumn{2}{|l|}{\textbf{Cows}} \\
\hline
\textbf{Pathogens} & \textbf{\%} & \textbf{n} & \textbf{\%} & \textbf{n} \\
\hline
E.coli* & 22.1 & 15 & 6.6 & 20 \\
\hline
Str. uberis* & 19.1 & 13 & 9.9 & 30 \\
... | PMC1687189_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Hybridization ID} & \textbf{ArrayDesign REF} & \textbf{ArrayData URI} & \textbf{DerivedArrayData Matrix URI} \\
\hline
Hyb 1 & SMD-10K & 1.txt & FGDM.txt \\
\hline
Hyb 2 & SMD-10K & 2.txt & FGDM.txt \\
\hline
Hyb 3 & SMD-10K & 3.txt & FGDM.txt \\
... | PMC1687205_table_6 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \multicolumn{2}{|l|}{\textbf{Respondents}} & \multicolumn{2}{|l|}{\textbf{Dropouts}} \\
\hline
\textbf{Characteristics at baseline} & \textbf{N} & \textbf{\%} & \textbf{N} & \textbf{\%} \\
\hline
\multicolumn{5}{|l|}{Age (years)} \\
\hline
$<$ 30 & 2... | PMC1693921_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{\# of carbons} & \textbf{Flavone} & \textbf{Product(s) and yields (\%)} & \textbf{Ref.} \\
\hline
15 & 5,7-dihydroxyflavone & 5,7-dihydroxyflavone-8-sulfate, 43 & [71] \\
\hline
22 & 5-hydroxy-7-benzyloxyflavone & 5,8-dihydroxy-7-benzyloxyflavone,... | PMC1697820_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{4} & \multicolumn{4}{|l|}{\textbf{Dose of ifosfamide}} \\
\hline
\textbf{9} & \textbf{g/m2 10} & \textbf{g/m2 12} & \textbf{g/m2 13} & \textbf{g/m2 14} \\
\hline
Hemoglobin 60 & 21/7 & 20/3 & 9/4.5 & 36/9 \\
\hline
Leukocytes 67 & 18/57 & 19/42 ... | PMC1698138_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Parameter} & \textbf{Control} & \textbf{Day 1 ICUa} & \textbf{Day 7 ICUb} \\
\hline
ADMA & 0.63 (0.57–0.71) & 0.89 (0.57–1.09) & 1.05 (0.71–1.32) \\
\hline
\end{tabular}}
\end{table} | PMC1751072_table_4 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
TBST+ (Subjects) & 47 & 102 \\
\hline
TBST- (Controls) & 78 & 142 \\
\hline
\end{tabular}}
\end{table} | PMC1764018_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Dengue serotype} & \multicolumn{3}{|l|}{\textbf{Data retrieved in 2004}} & \multicolumn{3}{|l|}{\textbf{Data retrieved in 2005}} \\
\hline
& \textbf{Unique sequences (\#)} & \multicolumn{2}{|l|}{\textbf{Minimal antigenic set}} & \textbf{Uni... | PMC1764481_table_4 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Author} & \textbf{Cases} & \textbf{Cause} & \textbf{Therapy} & \textbf{Outcome} & \textbf{Comments} \\
\hline
Smrkolj V. 1995 & two & Homicidal attempt & Surgery & Died & Left hemiplegia, right internal carotid artery thrombosis \\
\hline
& ... | PMC1766346_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Marker spacing (kb)} & \textbf{|D'|} & \textbf{number of markers} \\
\hline
6.6 kb & 0.88 & 500 k \\
\hline
20 kb & 0.73 & 166 k \\
\hline
33 kb & 0.64 & 100 k \\
\hline
100 kb & 0.45 & 33 k \\
\hline
166 kb & 0.36 & 20 k \\
\hline
\end{tabular}}
\e... | PMC1766938_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Motif} & \textbf{Zg-score} & \textbf{Z -score} & \textbf{G -score} & \textbf{Number of occurrences} & \textbf{Number of promoters} & \textbf{Known motifs} \\
\hline
\multicolumn{7}{|l|}{Word cluster 1:} \\
\hline
TTGGCGCCTC(-) & 3.768 & 11.6... | PMC1779545_table_1 |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 2